This role offers high-impact ownership of a complex Phase 2b inflammation study from start-up through closeout.
Base: $95,000.00 - $175,700.00; Bonus/Equity: Eligibility for commissions/bonus based on performance; Benefits: Medical, Dental, Vision, 401k match, PTO
Must-have
Nice-to-have
Not specified